These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 12747542)

  • 1. A 'Fine' chemical industry for life science products: green solutions to chemical challenges.
    Bruggink A; Straathof AJ; van der Wielen LA
    Adv Biochem Eng Biotechnol; 2003; 80():69-113. PubMed ID: 12747542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The production of fine chemicals by biotransformations.
    Straathof AJ; Panke S; Schmid A
    Curr Opin Biotechnol; 2002 Dec; 13(6):548-56. PubMed ID: 12482513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New opportunities for biocatalysis: making pharmaceutical processes greener.
    Woodley JM
    Trends Biotechnol; 2008 Jun; 26(6):321-7. PubMed ID: 18436317
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Industrial biocatalysis.
    Zaks A
    Curr Opin Chem Biol; 2001 Apr; 5(2):130-6. PubMed ID: 11282338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards novel processes for the fine-chemical and pharmaceutical industries.
    Huisman GW; Gray D
    Curr Opin Biotechnol; 2002 Aug; 13(4):352-8. PubMed ID: 12323358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Nepveux K; Sherlock JP; Futran M; Thien M; Krumme M
    J Pharm Sci; 2015 Mar; 104(3):850-64. PubMed ID: 25630721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
    Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
    J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biocatalytic membrane reactors: applications and perspectives.
    Giorno L; Drioli E
    Trends Biotechnol; 2000 Aug; 18(8):339-49. PubMed ID: 10899815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Srai JS; Badman C; Krumme M; Futran M; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocatalysis for pharmaceutical intermediates: the future is now.
    Pollard DJ; Woodley JM
    Trends Biotechnol; 2007 Feb; 25(2):66-73. PubMed ID: 17184862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Process technology for multi-enzymatic reaction systems.
    Xue R; Woodley JM
    Bioresour Technol; 2012 Jul; 115():183-95. PubMed ID: 22531164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered enzymes for chemical production.
    Luetz S; Giver L; Lalonde J
    Biotechnol Bioeng; 2008 Nov; 101(4):647-53. PubMed ID: 18814289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. White paper on continuous bioprocessing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Konstantinov KB; Cooney CL
    J Pharm Sci; 2015 Mar; 104(3):813-20. PubMed ID: 25417595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Innovative oxidation methods in fine chemicals synthesis.
    Poechlauer P; Skranc W
    Curr Opin Drug Discov Devel; 2002 Nov; 5(6):1000-8. PubMed ID: 12478730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated operation of continuous chromatography and biotransformations for the generic high yield production of fine chemicals.
    Bechtold M; Makart S; Heinemann M; Panke S
    J Biotechnol; 2006 Jun; 124(1):146-62. PubMed ID: 16516996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy for the individual: Towards patient integration into the manufacturing and provision of pharmaceuticals.
    Govender R; Abrahmsén-Alami S; Larsson A; Folestad S
    Eur J Pharm Biopharm; 2020 Apr; 149():58-76. PubMed ID: 31982577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
    Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
    J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Provable Data Integrity in the Pharmaceutical Industry Based on Version Control Systems and the Blockchain.
    Steinwandter V; Herwig C
    PDA J Pharm Sci Technol; 2019; 73(4):373-390. PubMed ID: 30770485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocatalysis: applications and potentials for the chemical industry.
    Thomas SM; DiCosimo R; Nagarajan V
    Trends Biotechnol; 2002 Jun; 20(6):238-42. PubMed ID: 12007491
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.